Health Canada Approves Relora Stress-Relief Supplement

April 10, 2013

Relora’s developer, Next Pharmaceuticals (Salinas, CA), says Relora works by “quieting the hypothalamic-pituitary-adrenal axis without causing drowsiness.”

Health Canada has issued Relora, a dietary supplement aimed at alleviating stress-related eating and promoting weight management, a Natural Product Number (#505349), enabling its sale in Canada.

Relora’s developer, Next Pharmaceuticals (Salinas, CA), says Relora works by “quieting the hypothalamic-pituitary-adrenal axis without causing drowsiness.” It is a blend of Magnolia officinalis and Phellodendron amurense bark extracts.

Relora has been sold in the United States since 2000 under patent (#6,582,735).